Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Search

Page Path

HOME
Search

3

Long-term Follow-up of Patients Treated with Interferon Alfa for Chronic Hepatitis B

Jong Eun Yeon, M.D., Yeon Seok Seo, M.D., Yoon Hong Kim, M.D., Sang Hoon Park, M.D., Oh Sang Kwon, M.D., Kwan Soo Byun, M.D., and Chang Hong Lee, M.D.

Clin Mol Hepatol. 1999;5(1):12-21. Published online January 1, 2000

View: 2278 Download: 18

The Degree of TGF-p1 and a-SMA Expression in Liver Tissues with its Prognostic Value for the Therapeutic Efficacy of Interferon in Chronic Hepatitis B

Bai Young Kim, hee Jeong Ahn*, Seong Wook Oh, Oun Mi Jeong, Yu Jeong Choi, Jin Hwan Kook, Kyung Chul Kim, Sung Pyo Hong, Seong Gyu Hwang, Pil Won Park and Kyu Sung Rim

Clin Mol Hepatol. 1998;4(4):317-329. Published online January 1, 2000

View: 1962 Download: 13

Efficacy of Combination of Interferon α 2a , Ribavirin and UDCA in the Treatment of Chronic Hepatitis C

Dong Jin Suh , Neung Hwa Park , Young Hwa Chung , Young Sang Lee

Clin Mol Hepatol. 1998;4(2):109-119.

View: 2398 Download: 14

Lipid Peroxidation in Chronic Liver Diseases Type B

Kyung Chul Kim , Kwan Sik Lee , Kwang Hyub Han , Won Choi , Chae Yoon Chon , Sang In Lee , Young Myung Moon , Jin Kyung Kang , In Suh Park , Hye Young Kim

Clin Mol Hepatol. 1997;3(1):40-49.

View: 2357 Download: 18

A Study on HBV Precore Mutant in Liver Tissues of Chronic Hepatitis B Patiets

Hae Chul Chung , Yeong Hong Park , Jung Myung Chung

Clin Mol Hepatol. 1996;2(2):145-159.

View: 2345 Download: 14

4

A Case of Hypothyroidism Induced by Alpha - Interferon Therapy for Chronic Hepatitis B

So Young Kwon , Jong Eun Yeon , Sei Hyun Baik , Jin Ho Kim , Young Tae Baik , Kwan Soo Byun , Chang Hong Lee

Clin Mol Hepatol. 1996;2(1):77-81.

View: 2121 Download: 12

Original Article

Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients

Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery

Received December 16, 2023 Accepted March 25, 2024

DOI: https://doi.org/10.3350/cmh.2023.0535 [Accepted]

View: 429 Download: 40

1 | 2 | 3 | 4 | 5 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

04 Days

*Last 12 months

MOST VIEWED (Last 6 months)

Viewed By 5608	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4830	MAFLD: How is it different from NAFLD?
Viewed By 4569	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3732	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3720	Global incidence and prevalence of nonalcoholic fatty liver disease

+more

MOST CITED (2022-2024)

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

+more

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: kasl@kams.or.kr

COUNTER

TODAY : 1618

TOTAL : 1813271